|
Baseline characteristics |
||||
| All |
Coagulopathy (n = 25) |
Mild or no coagulopathy (n = 35) |
P value |
|
|
|
||||
| Age in years |
42 (16–80) |
42 (16–80) |
34 (16–63) |
0.002a |
| Aetiology |
||||
| Acute liver failure |
25 (42%) |
10 (40%) |
15 (43%) |
|
| Chronic liver disease |
19 (32%) |
9 (36%) |
10 (29%) |
|
| Post-transplant |
9 (15%) |
5 (20%) |
4 (11%) |
|
| Other |
7 (12%) |
1 (4%) |
6 (17%) |
|
| Severity of disease |
||||
| APACHE II score |
19 (4–30) |
20 (9–28) |
19 (4–30) |
|
| SOFA score |
13 (3–22) |
14 (10–22) |
12 (3–18) |
0.002a |
| Duration of mechanical ventilation |
||||
| Duration of CMVb |
7 (0–22) |
7 (0–19) |
6 (1–22) |
|
| Tracheostomy method |
||||
| Blue Rhino® |
43 |
17 |
26 |
|
|
Values are presented as median (and range or percentage). a p < 0.05 significant. bDuration of controlled mechanical ventilation in days prior to procedure. APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sepsis-related Organ Failure Assessment. | ||||
Auzinger et al. Critical Care 2007 11:R110 doi:10.1186/cc6143 |
||||